The antibiotics crisis. We're in the midst of an escalating arms race with the microbe, and we may be losing.
Nash
J M
JM
D000081:Acetamides / Q000138:chemical synthesis; D000900:Anti-Bacterial Agents / Q000138:chemical synthesis; D000890:Anti-Infective Agents / Q000138:chemical synthesis* / Q000627:therapeutic use; D017576:Daptomycin / Q000138:chemical synthesis; D015195:Drug Design; D004352:Drug Resistance, Microbial; D006300:Health Services Misuse; D006801:Humans; D000069349:Linezolid; D023303:Oxazolidinones / Q000138:chemical synthesis; D010349:Patient Compliance; D010597:Pharmacogenetics / Q000639:trends; D014481:United States
D000081:Acetamides; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D023303:Oxazolidinones; D000069349:Linezolid; D017576:Daptomycin